CUV 1.42% $13.90 clinuvel pharmaceuticals limited

getting set to move?, page-11

  1. 1,571 Posts.
    re: ept dont get phased A multi billion dollar market has certainly not been factored into this share price. What may have been is the expectancy of a succesful trial and then the move to commercialisation will be when this stock really moves, as the market for this stock is in the VCR, CSL and COH range in my opinion! I do hold the stock and have been topping up over the past few days.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.